Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
Abstract Glucagon-like peptide-1 receptor (GLP-1R) agonists are now commonly used to treat type 2 diabetes and obesity. GLP-1R signaling in the spinal cord has been suggested to account for the mild tachycardia caused by GLP-1R agonists, and may also be involved in the therapeutic effects of these d...
Auteurs principaux: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Nature Portfolio
2024-06-01
|
Collection: | Scientific Reports |
Accès en ligne: | https://doi.org/10.1038/s41598-024-65442-1 |